CIK 0001439725 · Non-accelerated filer<br>Smaller reporting company
BIODESIX INC
Sign in to watch- Ticker
- BDSX
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203986492
- Phone
- 303-417-0500
- Business address
- 919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
- Open-market buys, last 90 days
- $1,001,990
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$1,001,990. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-30 | PATIENCE JOHN Director | Option exercise | +22,874 | 407,486 | ||
| 2025-06-30 | PATIENCE JOHN Director | Option exercise · Restricted Stock Units | −22,874 | 45,747 | ||
| 2025-05-20 | Strobeck Matthew Director | Grant or award · Restricted Stock Units | +80,525 | 80,525 | ||
| 2025-05-20 | Strobeck Matthew Director | Grant or award · Stock Options (Right to Buy) | +42,010 | 42,010 | ||
| 2025-05-20 | PATIENCE JOHN Director | Grant or award · Restricted Stock Units | +68,621 | 68,621 | ||
| 2025-05-20 | PATIENCE JOHN Director | Grant or award · Stock Options (Right to Buy) | +42,010 | 42,010 | ||
| 2025-05-20 | MASSARANY HANY Director | Grant or award · Restricted Stock Units | +86,477 | 86,477 | ||
| 2025-05-20 | MASSARANY HANY Director | Grant or award · Stock Options (Right to Buy) | +42,010 | 42,010 | ||
| 2025-05-20 | Kennedy Lawrence T. Jr Director | Grant or award · Restricted Stock Units | +68,621 | 68,621 | ||
| 2025-05-20 | Kennedy Lawrence T. Jr Director | Grant or award · Stock Options (Right to Buy) | +42,010 | 42,010 | ||
| 2025-05-20 | Kayyem Jon Faiz Director | Grant or award · Restricted Stock Units | +68,621 | 68,621 | ||
| 2025-05-20 | Kayyem Jon Faiz Director | Grant or award · Stock Options (Right to Buy) | +42,010 | 42,010 | ||
| 2025-05-20 | Franchi Jean M. Director | Grant or award · Restricted Stock Units | +92,429 | 92,429 | ||
| 2025-05-20 | Franchi Jean M. Director | Grant or award · Stock Options (Right to Buy) | +42,010 | 42,010 | ||
| 2025-05-19 | SCHULER JACK W Director | Purchase | +723,239 | $0.34 | $247K | 20,918,174 |
| 2025-05-16 | SCHULER JACK W Director | Purchase | +4,000,000 | $0.27 | $1.1M | 20,194,935 |
| 2025-05-13 | Vazquez Chris Chief Accounting Officer | Sale | −112 | $0.35 | $40 | 18,001 |
| 2025-05-13 | Pestano Gary Anthony Chief Development Officer | Sale | −222 | $0.35 | $78 | 156,941 |
| 2025-05-13 | O'Kane Kieran Chief Commercial Officer | Sale | −238 | $0.35 | $84 | 139,052 |
| 2025-05-13 | Hutton Scott President & CEO | Sale | −1,887 | $0.35 | $666 | 720,384 |
Page 7 of 14 · 274 trades